Literature DB >> 26315932

Impairment of neutrophil oxidative burst in children with sickle cell disease is associated with heme oxygenase-1.

Ceri Evans1, Katharine Orf1, Erzsebet Horvath2, Michael Levin3, Josu De La Fuente4, Subarna Chakravorty4, Aubrey J Cunnington5.   

Abstract

Sickle cell disease is a risk factor for invasive bacterial infections, and splenic dysfunction is believed to be the main underlying cause. We have previously shown that the liberation of heme in acute hemolysis can induce heme oxygenase-1 during granulopoiesis, impairing the ability of developing neutrophils to mount a bactericidal oxidative burst, and increasing susceptibility to bacterial infection. We hypothesized that this may also occur with the chronic hemolysis of sickle cell disease, potentially contributing to susceptibility to infections. We found that neutrophil oxidative burst activity was significantly lower in treatment-naïve children with sickle cell disease compared to age-, gender- and ethnicity-matched controls, whilst degranulation was similar. The defect in neutrophil oxidative burst was quantitatively related to both systemic heme oxygenase-1 activity (assessed by carboxyhemoglobin concentration) and neutrophil mobilization. A distinct population of heme oxygenase-1-expressing cells was present in the bone marrow of children with sickle cell disease, but not in healthy children, with a surface marker profile consistent with neutrophil progenitors (CD49d(Hi) CD24(Lo) CD15(Int) CD16(Int) CD11b(+/-)). Incubation of promyelocytic HL-60 cells with the heme oxygenase-1 substrate and inducer, hemin, demonstrated that heme oxygenase-1 induction during neutrophilic differentiation could reduce oxidative burst capacity. These findings indicate that impairment of neutrophil oxidative burst activity in sickle cell disease is associated with hemolysis and heme oxygenase-1 expression. Neutrophil dysfunction might contribute to risk of infection in sickle cell disease, and measurement of neutrophil oxidative burst might be used to identify patients at greatest risk of infection, who might benefit from enhanced prophylaxis. Copyright© Ferrata Storti Foundation.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26315932      PMCID: PMC4666326          DOI: 10.3324/haematol.2015.128777

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  55 in total

1.  Carboxyhemoglobin levels in patients with sickle-cell anemia: relationship to hemolytic and vasoocclusive severity.

Authors:  D A Sears; M M Udden; L J Thomas
Journal:  Am J Med Sci       Date:  2001-12       Impact factor: 2.378

Review 2.  Infection in sickle cell disease: a review.

Authors:  Catherine Booth; Baba Inusa; Stephen K Obaro
Journal:  Int J Infect Dis       Date:  2009-06-03       Impact factor: 3.623

3.  Endogenous carbon monoxide production in patients with hemolytic anemia.

Authors:  R F Coburn; W J Williams; S B Kahn
Journal:  J Clin Invest       Date:  1966-04       Impact factor: 14.808

4.  Safety of hydroxyurea in children with sickle cell anemia: results of the HUG-KIDS study, a phase I/II trial. Pediatric Hydroxyurea Group.

Authors:  T R Kinney; R W Helms; E E O'Branski; K Ohene-Frempong; W Wang; C Daeschner; E Vichinsky; R Redding-Lallinger; B Gee; O S Platt; R E Ware
Journal:  Blood       Date:  1999-09-01       Impact factor: 22.113

5.  HO-1 underlies resistance of AML cells to TNF-induced apoptosis.

Authors:  Stuart A Rushworth; David J MacEwan
Journal:  Blood       Date:  2008-01-17       Impact factor: 22.113

6.  Heme oxygenase-1 gene promoter polymorphism is associated with reduced incidence of acute chest syndrome among children with sickle cell disease.

Authors:  Christopher J Bean; Sheree L Boulet; Dorothy Ellingsen; Meredith E Pyle; Emily A Barron-Casella; James F Casella; Amanda B Payne; Jennifer Driggers; Heidi A Trau; Genyan Yang; Kimberly Jones; Solomon F Ofori-Acquah; W Craig Hooper; Michael R DeBaun
Journal:  Blood       Date:  2012-09-10       Impact factor: 22.113

7.  Impact of hydroxyurea on clinical events in the BABY HUG trial.

Authors:  Courtney D Thornburg; Beatrice A Files; Zhaoyu Luo; Scott T Miller; Ram Kalpatthi; Rathi Iyer; Phillip Seaman; Jeffrey Lebensburger; Ofelia Alvarez; Bruce Thompson; Russell E Ware; Winfred C Wang
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

Review 8.  Heme oxygenase and carbon monoxide initiate homeostatic signaling.

Authors:  Martin Bilban; Arvand Haschemi; Barbara Wegiel; Beek Y Chin; Oswald Wagner; Leo E Otterbein
Journal:  J Mol Med (Berl)       Date:  2007-11-22       Impact factor: 4.599

9.  Positive blood cultures in sickle cell disease: time to positivity and clinical outcome.

Authors:  Cynthia F Norris; Kim Smith-Whitley; Karin L McGowan
Journal:  J Pediatr Hematol Oncol       Date:  2003-05       Impact factor: 1.289

Review 10.  Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins.

Authors:  Dominik J Schaer; Paul W Buehler; Abdu I Alayash; John D Belcher; Gregory M Vercellotti
Journal:  Blood       Date:  2012-12-20       Impact factor: 22.113

View more
  10 in total

1.  Whole-Blood Transcriptional Signatures Composed of Erythropoietic and NRF2-Regulated Genes Differ Between Cerebral Malaria and Severe Malarial Anemia.

Authors:  Srinivas Nallandhighal; Gregory S Park; Yen-Yi Ho; Robert O Opoka; Chandy C John; Tuan M Tran
Journal:  J Infect Dis       Date:  2019-01-01       Impact factor: 5.226

Review 2.  Disseminated infections with antibiotic-resistant non-typhoidal Salmonella strains: contributions of host and pathogen factors.

Authors:  Kristen L Lokken; Gregory T Walker; Renée M Tsolis
Journal:  Pathog Dis       Date:  2016-10-08       Impact factor: 3.166

3.  Strategies to increase access to basic sickle cell disease care in low- and middle-income countries.

Authors:  Meghna Dua; Halima Bello-Manga; Yvonne M Carroll; Aisha Amal Galadanci; Umma Abdulsalam Ibrahim; Allison A King; Ayobami Olanrewaju; Jeremie H Estepp
Journal:  Expert Rev Hematol       Date:  2022-04-12       Impact factor: 2.819

Review 4.  Malaria, anemia, and invasive bacterial disease: A neutrophil problem?

Authors:  Jason P Mooney; Lauren J Galloway; Eleanor M Riley
Journal:  J Leukoc Biol       Date:  2018-12-20       Impact factor: 4.962

5.  Arterial carboxyhaemoglobin levels in children admitted to PICU: A retrospective observational study.

Authors:  Ankur Chawla; Samiran Ray; Adela Matettore; Mark J Peters
Journal:  PLoS One       Date:  2019-03-07       Impact factor: 3.240

Review 6.  Innate immune cells, major protagonists of sickle cell disease pathophysiology.

Authors:  Slimane Allali; Thiago Trovati Maciel; Olivier Hermine; Mariane de Montalembert
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

7.  Machine Learning to Quantitate Neutrophil NETosis.

Authors:  Laila Elsherif; Noah Sciaky; Carrington A Metts; Md Modasshir; Ioannis Rekleitis; Christine A Burris; Joshua A Walker; Nadeem Ramadan; Tina M Leisner; Stephen P Holly; Martis W Cowles; Kenneth I Ataga; Joshua N Cooper; Leslie V Parise
Journal:  Sci Rep       Date:  2019-11-15       Impact factor: 4.379

8.  Prognostic value of carboxyhemoglobin in pediatric intensive care unit.

Authors:  Mehmet Alakaya; Ali Ertug Arslankoylu
Journal:  Pak J Med Sci       Date:  2022 Sep-Oct       Impact factor: 2.340

9.  Relationship between Anaemia, Haemolysis, Inflammation and Haem Oxygenase-1 at Admission with Sepsis: a pilot study.

Authors:  Phebe Ekregbesi; Manu Shankar-Hari; Christian Bottomley; Eleanor M Riley; Jason P Mooney
Journal:  Sci Rep       Date:  2018-07-25       Impact factor: 4.379

10.  Pathogenic signature of invasive non-typhoidal Salmonella in Africa: implications for vaccine development.

Authors:  Giulia Piccini; Emanuele Montomoli
Journal:  Hum Vaccin Immunother       Date:  2020-07-21       Impact factor: 3.452

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.